2024-516369-36-00CompletedPhase 1
A Phase 1 Study of HMPL-306 in Advanced Hematological Malignancies with Isocitrate Dehydrogenase (IDH) Mutations
Source: EU CTIS (euclinicaltrials.eu) · Last updated 21 Aug 2024
- Status (registry)
- Completed
- Phase (registry)
- Phase 1
- Study type
- Interventional
- Enrollment
- 37 (actual)
- First submitted
- 14 Aug 2024
- Start date
- 9 Feb 2021
- Lead sponsor
- Hutchmed Ltd.
- EU CT number
- 2024-516369-36-00
- EudraCT number
- 2020-003751-15
What you commit to
- Study type: Interventional · Phase 1
- Participants enrolled: 37
- 8 sites in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of EU CTIS (euclinicaltrials.eu). It describes the study design.
Sites (8)
Sites in registry order. Save your city in your profile to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Hospital Universitari Vall d'Hebron | Barcelona | Spain | Completed |
| Institut Catala D'oncologia | L'Hospitalet de Llobregat | Spain | Completed |
| Hospital Universitario 12 de Octubre | Madrid | Spain | Completed |
| Hospital Universitario Fundación Jiménez Díaz | Madrid | Spain | Completed |
| Clínica Universidad de navarra | Pamplona | Spain | Completed |
| Hospital Universitario De Salamanca | Salamanca | Spain | Completed |
| Hospital Universitario Y Politecnico La Fe | Valencia | Spain | Completed |
| Hospital Clinico Universitario de Valencia | Valencia | Spain | Completed |
This page is information, not medical advice. Discuss any trial with your doctor.